Miami, Florida – The International Society for Stem Cell Application (ISSCA), a
distinguished division of the Global Stem Cells Group (GSCG), is excited to announce its
highly anticipated international conference on Regenerative Medicine and Cellular
Therapies. Scheduled to unfold in the dynamic city of Lima, Peru, this groundbreaking
event will span two immersive days, from September 6th to 7th, 2024. Day one will be
dedicated to enlightening conferences, while day two will offer hands-on sessions,
providing attendees with a comprehensive learning experience.
Renowned urologist Dr. Jorge Saldaña, certified by ISSCA and highly regarded in the
region, will play a key role in organizing the conference. The event will also serve as the
venue for Dr. Saldaña’s appointment as the director of the ISSCA chapter in Peru. This
significant appointment is scheduled for September 6th, further underscoring his
dedication to advancing regenerative medicine not only in Peru but also in neighboring
regions of Latin America.
The conference aims to assemble leading scientists and medical professionals
worldwide, offering a unique platform to explore and discuss the latest advancements
in regenerative medicine. With an array of elite speakers, including distinguished
scientists and physicians renowned for their contributions to the field, attendees can
anticipate gaining profound insights into the cutting-edge clinical applications of stem
cell therapies.
Attendees are expected to be at the forefront of revolutionary technologies in
regenerative medicine. From the latest breakthroughs reshaping healthcare to
innovative tools enhancing clinical practice, participants will uncover advancements
poised to elevate their practice and enhance patient care.
This conference provides a holistic understanding of regenerative medicine, spanning
foundational principles to cutting-edge applications. Attendees are anticipated to leave
equipped with the essential knowledge to navigate the rapidly evolving landscape of
regenerative medicine.
Beyond theoretical discourse, the conference offers invaluable hands-on training
sessions led by ISSCA-certified instructors. Attendees will gain practical experience in
both aesthetic and clinical applications of stem cell therapy, ensuring they leave
equipped with skills ready for immediate implementation.
ISSCA is proud to bring its expertise back to Lima, Peru, reaffirming its presence in the
southern cone with this global conference. Benito Novas, founder of Global Stem Cells
Group and head of relationships of ISSCA, expresses his excitement, stating, “I’m thrilled
to return to Peru with new technologies in the field of regenerative medicine. We will be
providing local doctors and neighboring regions with the latest advancements in the
field. Regenerative medicine is the future of healthcare as more research is conducted
and products are developed to offer superior services.”
Benito adds,”The conference will feature world-renowned experts engaging directly with
live trainees and patients to impart diverse cellular and procedural therapy techniques.
These sessions will utilize locally available tools, ensuring practical applicability and
relevance to the attendees’ contexts.”
As an acclaimed stakeholder in regenerative medicine and stem cell therapy, ISSCA
offers a globally recognized certification to physicians and professionals, highlighting
its fascinating track record in this highly sought-after field. According to Dr. Saldaña,
“ISSCA has always been a pioneer in the world of regenerative medicine, serving as a
worldwide reference. Having them here once again with their world conference is a
fantastic opportunity, and I’m genuinely delighted to be part of this momentous event”
The Conference considers the needs of local trainees using a thorough scheduling
process. Initial consultations between the trainees and ISSCA will inform equipment and
kits availability, materials, underlying costs, and any other needs to be met during the
main event.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary
community of scientists and physicians who aspire to treat diseases and lessen human
suffering through advances in science, technology, and the practice of regenerative
medicine. ISSCA serves its members through advancements made in the specialty of
regenerative medicine.
The mission of ISSCA is to establish itself as a global leader in regenerative medicine
certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the
importance of standards and certifications in regenerative medicine as a medical
specialty. To help more people, both locally and globally, as the demand for more
doctors interested in and comfortable with regenerative medicine surges. ISSCA’s
mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell
medicine and research. The company uses its network to bring leadership in
regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to
patients worldwide. The company also partners with policymakers, educators, and
regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol
MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website
www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking
statements include, but are not limited to, statements that express our intentions,
beliefs, expectations, strategies, predictions, or any other information relating to our
future activities or other future events or conditions. These statements are based on
current expectations, estimates, and projections about our business based partly on
assumptions made by management. These statements are not guarantees of future
performance and involve risks, uncertainties, and assumptions that are difficult to
predict. Therefore, actual outcomes and results may and are likely to differ materially
from what is expressed or forecasted in forward-looking statements due to numerous
factors. Any forward-looking statements speak only as of the date of this news release,
and The Global Stem Cells Group undertakes no obligation to update any forward-
looking statement to reflect events or circumstances after the date of this news release.
This press release does not constitute a public offer of any securities for sale. Any
securities offered privately will not be or have not been registered under the Act and
may not be offered or sold in the United States absent registration or an applicable
exemption from registration requirements.